Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-18

Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in Patients With Anemia as a Result of Advanced Cancer and Treatment With Aggressive Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and effectiveness of epoetin alfa for treating anemia in patients with advanced cancer undergoing aggressive chemotherapy; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia, Neoplasms | Phase 2 | Status: COMPLETED